Atara Biotherapeutics

$16.78
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.17 (+1.02%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ATRA and other stocks, options, and ETFs commission-free!

About ATRA

Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. The listed name for ATRA is Atara Biotherapeutics, Inc. Common Stock.

CEO

Pascal Touchon

Employees

393

Headquarters

South San Francisco, California

Founded

2012

Market Cap

1.41B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

667.07K

High Today

$17.15

Low Today

$16.29

Open Price

$16.72

Volume

572.92K

52 Week High

$28.20

52 Week Low

$4.52

Analyst Ratings

64%

of 11 ratings

Buy

64%

Hold

27%

Sell

ATRA Earnings

-$1.60

-$1.07

-$0.53

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

-$0.74 per share

Actual

Available Mar 1, After Hours